Interleukin-2 for Refractory Chronic Spontaneous Urticaria

Clinical trial NCT06924762 · RECRUITING

Trial details

NCT number: NCT06924762
Sponsor: Second Xiangya Hospital of Central South University
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chronic Spontaneous Uriticaria

Start date: 2025-03-19
Primary completion: 2025-12-31
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.